Intrauterine Devices (IUD) Market

Global Intrauterine Devices (IUD) Market Size (2024 to 2032)

In 2023,the global intrauterine devices (IUD) market was valued at USD 16385.99 million and it is expected to reach USD 2566.63 million by 2032 from USD 1766.59 million in 2024, growing at a CAGR of 4.78 % during the forecast period. 

MARKET DRIVERS

The growing awareness of contraception worldwide is one of the key factors driving the growth of the intrauterine devices market.

The awareness among people regarding contraception has improved significantly in recent years owing to the increased number of awareness campaigns, educational programs and improved access to information. As a result, the usage of IUDs has increased as these are considered as a reliable and effective contraceptive method. The growing number of initiatives from governmental organizations, non-profit organizations and healthcare organizations on family planning initiatives to address population growth and promote reproductive health contributes to the growth of the intrauterine devices market. An increasing number of public health campaigns and initiatives focussing on women’s health have also boosted the awareness of contraception and increased the adoption of intrauterine devices. The use of social media and digital platforms have also played a significant role in the increasing awareness of contraception including IUDs.

The high efficacy and convenience of intrauterine devices drive market growth. Intrauterine devices are popular for their high effectiveness and the failure rate of IUDs is less than 1%. Considering the high success rate of intrauterine devices, people who want to seek long-term and highly efficient contraception options have been increasingly adopting these devices. The long-acting nature of intrauterine devices further boosts the adoption of these devices. The average protection that IUDs offer ranges from 3 years to 10 years. The long-duration effectiveness of IUDs has been offering sustained contraceptive coverage and peace of mind to users. The convenience and ease of use of intrauterine devices compared to other contraceptive methods further drives the usage of these devices and contribute to market growth.

The growing number of initiatives from several governments aiming to promote family planning, reduce unintended pregnancies and improve women's healthcare access facilities the intrauterine devices market growth. The growing emphasis on women's health and empowerment globally, increasing investments in research and development of female contraceptives, including IUDs, rising population and increasing urbanization in developing countries, increasing demand for effective contraception methods and rising preference from women for non-hormonal contraception options such as IUDs fuel the market’s growth rate.

Continuous advancements in IUD technology, growing healthcare expenditure, improved insurance coverage for contraception, rising incidence of sexually transmitted infections such as HPV and chlamydia, increasing preference for non-invasive and minimally invasive procedures for birth control, growing population and delayed pregnancies and increasing number of collaborations between pharmaceutical companies, healthcare providers and non-profit organizations to increase the availability of IUDs in both developed and developing regions further promote the growth of the intrauterine devices market.

MARKET RESTRAINS

Poor awareness and education regarding IUDs are one of the key factors hampering the market growth. Cultural and societal factors, cost and affordability of intrauterine devices further hinder the market growth, The accessibility and availability challenges and fear of pain and discomfort with the usage of IUDs impede the market growth. Perceived side effects, safety concerns, lack of healthcare provider training and familiarity, religious or ethical opposition, misconceptions and stigma surrounding IUDs further inhibits the growth rate of the global market. The presence of alternative contraceptive options is another significant roadblock to the market’s growth rate.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Intrauterine Devices Market By Product Type

Based on product type, the hormonal intrauterine devices segment is expected to hold the leading share of the global market during the forecast period. The high efficacy and effectiveness of hormonal IUDs are one of the major factors propelling segmental growth. The convenience and ease of use, long-acting reversible contraception and reduction of menstrual bleeding and cramps contribute to the segment’s growth rate. Hormonal benefits, such as alleviating symptoms of endometriosis, growing awareness and acceptance of hormonal contraceptives, rising demand for non-daily contraceptive options, expansion of healthcare coverage and insurance reimbursement and growing prevalence of hormonal contraceptive use further boost the growth of the hormonal IUDs segment.

On the other hand, the copper segment accounted for a considerable share of the market in 2023and is expected to grow at a steady CAGR during the forecast period. Copper IUDs are a non-hormonal and hormone-free contraception option, which is one of the major factors driving segmental growth. The high efficacy of copper IUDs in preventing pregnancy, growing demand for non-hormonal contraceptive choices, favorable options for women with hormonal sensitivities or contraindications, increasing awareness and preference for non-hormonal contraception and expansion of healthcare coverage and insurance reimbursement further contribute to the segment’s growth rate.

REGIONAL ANALYSIS

North America held the major share of the global market in 2023and is expected to grow at a healthy CAGR during the forecast period. The growing awareness and acceptance of IUDs as a reliable contraceptive option, favorable government policies and initiatives promoting family planning and reproductive health and growing emphasis on women's healthcare and access to contraception in North America majorly propel the North American intrauterine devices market growth. Technological advancements and availability of advanced IUD options, high healthcare expenditure, insurance coverage and rising preference for long-acting reversible contraception further drive the North American market growth. The U.S. had the leading share of the North American market in 2023and is expected to register a notable CAGR during the forecast period owing to the growing usage of IUDs and increasing awareness of the benefits of intrauterine devices among the women population of the U.S. As per the data published by the Guttmacher Institute, an estimated 12.6% of the women population in the U.S. aged between 15 to 49 years use IUDs for contraception. The Canadian market is predicted to grow at a healthy CAGR during the forecast period owing to the increasing number of initiatives by the Canadian government. The Canadian government offers universal healthcare coverage that includes IUDs as part of contraceptive services.

Europe held a substantial share of the global market in 2023and is projected to grow at a noteworthy CAGR during the forecast period. High acceptance and use of IUDs in Europe as a preferred contraceptive method is one of the key factors propelling the European IUDs market growth. The presence of well-established healthcare systems with easy access to reproductive health services and supportive government policies and initiatives promoting family planning and women's health contribute to the European market growth. The rising emphasis on long-acting reversible contraception options, increasing awareness and education on the benefits and effectiveness of IUDs and growing trend of delayed pregnancies and the focus on the spacing between births further fuel the growth rate of the European market. Countries such as Sweden, Denmark, and Norway are estimated to hold the major share of the European market during the forecast period owing to the high usage of IUDs in these countries.

APAC is a lucrative regional market for intrauterine devices and is anticipated to register the highest CAGR during the forecast period. Factors such as a rapidly growing population, increasing need for effective contraception methods, growing number of initiatives and programs from the governments of APAC region promoting family planning and reproductive health, increasing awareness and acceptance of modern contraception options, expansion of healthcare infrastructure and accessibility to reproductive health services primarily drive the growth of the IUDs market in the Asia-Pacific region. Rising focus on women's empowerment and reproductive rights, rapid urbanization and changing lifestyle patterns leading to increased adoption of modern contraception in APAC further boost the growth rate of the APAC market. China and India had the leading share of the APAC market in 2023and the domination of these countries in the APAC region is expected to continue throughout the forecast period.

Latin America captured a considerable share of the global market in 2023and is estimated to grow at a healthy growth rate during the forecast period. The growing access to reproductive health services and contraceptive methods and an increasing number of initiatives from the governments of Latin America to promote family planning and reproductive health education majorly drive the Latin American intrauterine devices market growth. The growing awareness of and preference for long-acting reversible contraception and increasing urbanization and changing cultural attitudes toward contraception contribute to the growth of the Latin American market. Brazil and Colombia are predicted to account for the largest share of the Latin American market during the forecast period.

The MEA market is anticipated to hold a moderate share of the global market during the forecast period. Factors such as the growing recognition of the importance of family planning and access to contraception, initiatives from governmental organizations to address population growth and improve maternal and child health, expanding healthcare infrastructure and access to reproductive health services drive the intrauterine devices market growth in MEA. South Africa and Morocco are estimated to play a leading role in the MEA market in the coming years.

KEY PLAYERS IN THE INTRAUTERINE DEVICES (IUD) MARKET

Some of the prominent companies leading the global intrauterine devices market profiled in this report are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc., Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd., Okamato Industries, Inc., and Pfizer.

RECENT HAPPENINGS IN THE GLOBAL INTRAUTERINE DEVICES (IUD) MARKET

• In February 2020, Twirla, a contraceptive batch launched by Agile Therapeutics was approved by U.S. FDA. In concern towards public safety, FDA has warned physicians not to recommend this product to those who suffer from cardiovascular disease.

• In September 2016, Bayers's intrauterine device, familiarly known as Kyleena, was approved by the U.S. FDA. This device is very useful in preventing pregnancy and has fewer side effects.

• In May 2016, Allergan launched “LILETTA,” which helps women in the U.S. military. It is an initial step by the company to help military servicewomen, and this product strengthened the company's position in the global intrauterine contraceptive devices market.

DETAILED SEGMENTATION OF THE GLOBAL INTRAUTERINE DEVICES (IUD) MARKET INCLUDED IN THIS REPORT 

This research report on the global intrauterine devices market has been segmented and sub-segmented based on the product type and region.

By Product Type

• Hormonal
• Copper

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa